
Olwen Pharmaceuticals Private Limited
About Olwen Pharmaceuticals Private Limited
Data last updated:
Olwen Pharmaceuticals Private Limited is a private limited company based in Jodhpur, Rajasthan, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 04 February 2022.
The company is registered with the Registrar of Companies (ROC), Jaipur, under CIN U24230RJ2022PTC079493. Its GSTIN is 08AADCO6963G1Z5 (Rajasthan). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It was formerly known as Olwen Pharmatceuticals Private Limited. It is led by directors Ram Kishor Prajapat and Swati Prajapat.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 230 A B Krishan Mander Gali Bhagat Ki Kothi, Jodhpur, Rajasthan, India – 342001.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.97 Cr, a growth of 37% compared to the previous year. For the same year it recorded a net profit of ₹93,248 (net margin 0.5%) and EBITDA of ₹1.58 Lakh (EBITDA margin 0.8%). Revenue has grown at a compounded annual rate (CAGR) of 238% over three years.
The company has about 49 employees on its provident fund (EPFO) records.
Company details
Contact details
Olwen Pharmaceuticals Private Limited's registered office is in Jodhpur, Rajasthan. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address230 A B Krishan Mander Gali Bhagat Ki Kothi, Jodhpur, Rajasthan, India – 342001
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Olwen Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Olwen Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Olwen Pharmaceuticals Private Limited, buy the company report.
Financials of Olwen Pharmaceuticals Private Limited
FY 2025 filings availableOlwen Pharmaceuticals Private Limited reported revenue of ₹1.97 Cr (up 37% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 238% over three years, including 37% growth in the latest year. EBITDA rose 9% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹1.58 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹93,248 | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 0.8% | |||
| Net Profit Margin | 0.5% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Olwen Pharmaceuticals Private Limited, buy the company report.
Board of directors of Olwen Pharmaceuticals Private Limited
Olwen Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ram Kishor Prajapat Also directs: Olwen Lifesciences Private Limited | Director | 04 Feb 2022 | 4 Years 9 Months | Current |
| Swati Prajapat Also directs: Olwen Lifesciences Private Limited | Director | 04 Feb 2022 | 4 Years 9 Months | Current |
Peer comparison
Olwen Pharmaceuticals Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Retort Pharmaceuticals Private Limited | ₹1.97 Cr (FY 2024) | -7.0% | Chennai, Tamil Nadu, India | |||
| Tooba Pharmaceuticals Private Limited | ₹1.97 Cr (FY 2024) | 57.0% | Aurangabad, Maharashtra, India | |||
| Fortune Pharmaceuticals India Private Limited | ₹1.97 Cr (FY 2024) | -74.0% | Samba, Jammu and Kashmir, India | |||
| Olwen Pharmaceuticals Private Limitedthis company | ₹1.97 Cr (FY 2025) | ₹93,248 | 0.5% | 37.0% | 49 | Jodhpur, Rajasthan, India |
| Shivaxy Pharmaceuticals Private Limited | ₹1.97 Cr (FY 2025) | -32.0% | Bangalore, Karnataka, India | |||
| Tapashi Pharmaceuticals Private Limited | ₹1.95 Cr (FY 2025) | -66.0% | Vadodara, Gujarat, India |
To see the full peer comparison of Olwen Pharmaceuticals Private Limited, buy the company report.
Auditor
Olwen Pharmaceuticals Private Limited is audited by ANKIT K C JAIN & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| ANKIT K C JAIN & ASSOCIATES | FY 2023 | 029014C |
Shareholding
The shareholding of Olwen Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Olwen Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Olwen Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Olwen Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Olwen Pharmaceuticals Private Limited has a workforce of 49 employees on its EPFO records as of May 2026.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 49 |
| FY 2025-26 |
To see the full employee and EPFO history of Olwen Pharmaceuticals Private Limited, buy the company report.
GST
Olwen Pharmaceuticals has 2 GST registrations: 2 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 08AADCO6963G1Z5 | Rajasthan | Active | 18 Feb 2022 |
| 23AADCO6963G1ZD | Madhya Pradesh | Active | 21 May 2022 |
To see the full GST registrations and return filing status of Olwen Pharmaceuticals Private Limited, buy the company report.
Recent activity
Olwen Pharmaceuticals Private Limited has 2 board changes on record since 2022: 2 appointments. The latest: Ram Kishor Prajapat was appointed as Director on 04 Feb 2022.
Frequently asked questions
Olwen Pharmaceuticals is an active private limited company based in Jodhpur, Rajasthan, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 04 February 2022 (4+ years old) and is registered under CIN U24230RJ2022PTC079493.
Olwen Pharmaceuticals has 2 current directors:
- Ram Kishor Prajapat - Director
- Swati Prajapat - Director
The latest financial statements of Olwen Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.
The GSTIN of Olwen Pharmaceuticals is 08AADCO6963G1Z5, registered in Rajasthan. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 23AADCO6963G1ZD (Madhya Pradesh).
The CIN (Corporate Identification Number) of Olwen Pharmaceuticals is U24230RJ2022PTC079493. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Olwen Pharmaceuticals was incorporated on 04 February 2022, making it 4+ years old. It is registered with the Registrar of Companies, Jaipur.
The peers of Olwen Pharmaceuticals by revenue are Retort Pharmaceuticals Private Limited, Tooba Pharmaceuticals Private Limited, Fortune Pharmaceuticals India Private Limited, Shivaxy Pharmaceuticals Private Limited, Tapashi Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Ram Kishor Prajapat was appointed as Director on 04 Feb 2022. Swati Prajapat was appointed as Director on 04 Feb 2022.
The registered office of Olwen Pharmaceuticals is at 230 A B Krishan Mander Gali Bhagat Ki Kothi, Jodhpur, Rajasthan, India – 342001.
Olwen Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.
Yes. Olwen Pharmaceuticals was formerly known as Olwen Pharmatceuticals Private Limited.

